Alpha Teknova, Inc. ( TKNO) - Key Metrics
TKNO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.23 | -$0.06 | -$0.01 | -$0.01 |
| 2026Q1 | $0.21 | -$0.08 | -$0.06 | -$0.07 |
| 2025Q4 | $0.19 | -$0.09 | -$0.01 | -$0.01 |
| 2025Q3 | $0.20 | -$0.08 | -$0.04 | -$0.04 |
| 2025Q2 | $0.19 | -$0.07 | -$0.04 | -$0.04 |
TKNO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -23.67 |
| 2026Q1 | 0% | -8.50 |
| 2025Q4 | 0% | -10.56 |
| 2025Q3 | 0% | -19.34 |
| 2025Q2 | 0% | -18.38 |
TKNO
Price: $7.08
52 week price:
Earnings Per Share: -0.32 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 32300
Market Capitalization: 469.1 million